Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse

Bone Marrow Transplant. 2016 Mar;51(3):466-9. doi: 10.1038/bmt.2015.296. Epub 2015 Dec 7.

Authors

E Xue^{1

2}, C Tresoldi³, E Sala¹, A Crippa³, B Mazzi², R Greco¹, C Messina¹, M G Carrabba¹, M T Lupo Stanghellini¹, S Marktel¹, C Corti¹, J Peccatori¹, M Bernardi¹, F Ciceri¹, L Vago^{1

2}

Affiliations

¹ Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.
² Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
³ Molecular Hematology Laboratory, IRCCS San Raffaele Scientific Institute, Milano, Italy.

PMID: 26642331
DOI: 10.1038/bmt.2015.296

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Allografts
Female
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / metabolism
Leukemia, Myeloid, Acute* / therapy
Male
Middle Aged
Monitoring, Physiologic / methods*
Mutation
Nuclear Proteins / genetics*
Nuclear Proteins / metabolism
Nucleophosmin
Predictive Value of Tests
Real-Time Polymerase Chain Reaction

Substances

NPM1 protein, human
Nuclear Proteins
Nucleophosmin